Apoptotic and non-apoptotic cell death induced by cis and trans analogues of a novel ammine(cyclohexylamine)dihydroxodichloroplatinum(IV) complex
It has been previously demonstrated that cisplatin induces apoptosis in the CH1 human ovarian carcinoma cell line. This study demonstrates that two novel platinum (Pt) analogues JM149 and JM335, which are the cis and trans geometry respectively of ammine(cyclohexylamine)dihydroxodichloroPt(IV), init...
Saved in:
| Published in: | British journal of cancer Vol. 74; no. 7; p. 1037 |
|---|---|
| Main Authors: | , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
01.10.1996
|
| Subjects: | |
| ISSN: | 0007-0920 |
| Online Access: | Get more information |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | It has been previously demonstrated that cisplatin induces apoptosis in the CH1 human ovarian carcinoma cell line. This study demonstrates that two novel platinum (Pt) analogues JM149 and JM335, which are the cis and trans geometry respectively of ammine(cyclohexylamine)dihydroxodichloroPt(IV), initiate apoptosis in this cell line at physiologically relevant concentrations (IC50 values 2 h drug exposure were 35.3 microM for JM149 and 18.7 microM for JM335). While at equimolar drug concentrations there was a 2-fold higher level of total platinum-DNA adducts following exposure to JM335 vs JM149, at equitoxic concentrations, levels were similar (80 vs 70 pmol Pt mg-1 DNA respectively). Following a 2 h incubation with 2 x IC50 of both drugs, cells rounded up and detached in a time-dependent manner but with the kinetics of apoptosis being more rapid for JM335. The majority of detached cells exhibited morphology associated with apoptosis which was further supported by the presence of a 50 kb fragment detected in DNA lysates prepared from these cells. JM149 induced apoptosis across a range of concentrations (2 x, 5 x and 10 x IC50) with a 50 kb DNA fragment being detected at all concentrations. However, in marked contrast to this, JM335 failed to cause apoptosis at 10 x IC50, the detached cells neither displaying apoptotic morphology nor a detectable 50 kb DNA fragment. Moreover, these detached cells showed evidence of extensive vesiculation while the DNA remained normal in appearance and thus appeared to have died by a non-apoptotic mode. Apoptosis also appeared to be induced to a lesser extent at 5 x IC50 of JM335 as demonstrated by a less intense 50 kb fragment compared with that seen at 2 x IC50. The main cell cycle effect of these drugs (at 2 x IC50) was a slowdown in S-phase traverse during which most but not all of the apoptosis appeared to occur. However, at 5 x IC50 of JM335 cells appeared frozen in all phases of the cell cycle with little progress from G1 to S accompanied by a build-up of cells in G2 indicative of a G2/M block. This difference in cell cycle effect may account for the reduced level of apoptosis at this concentration and a failure to engage apoptosis at higher concentrations. These data suggest that the nature of the platinum drug (and consequently, the nature of resultant DNA damage) may have important implications in determining the rate and mechanism of cell death in this cell line. The cell death effects observed with the trans complex JM335 may correlate with the induction of DNA single-strand breaks in this cell line. |
|---|---|
| AbstractList | It has been previously demonstrated that cisplatin induces apoptosis in the CH1 human ovarian carcinoma cell line. This study demonstrates that two novel platinum (Pt) analogues JM149 and JM335, which are the cis and trans geometry respectively of ammine(cyclohexylamine)dihydroxodichloroPt(IV), initiate apoptosis in this cell line at physiologically relevant concentrations (IC50 values 2 h drug exposure were 35.3 microM for JM149 and 18.7 microM for JM335). While at equimolar drug concentrations there was a 2-fold higher level of total platinum-DNA adducts following exposure to JM335 vs JM149, at equitoxic concentrations, levels were similar (80 vs 70 pmol Pt mg-1 DNA respectively). Following a 2 h incubation with 2 x IC50 of both drugs, cells rounded up and detached in a time-dependent manner but with the kinetics of apoptosis being more rapid for JM335. The majority of detached cells exhibited morphology associated with apoptosis which was further supported by the presence of a 50 kb fragment detected in DNA lysates prepared from these cells. JM149 induced apoptosis across a range of concentrations (2 x, 5 x and 10 x IC50) with a 50 kb DNA fragment being detected at all concentrations. However, in marked contrast to this, JM335 failed to cause apoptosis at 10 x IC50, the detached cells neither displaying apoptotic morphology nor a detectable 50 kb DNA fragment. Moreover, these detached cells showed evidence of extensive vesiculation while the DNA remained normal in appearance and thus appeared to have died by a non-apoptotic mode. Apoptosis also appeared to be induced to a lesser extent at 5 x IC50 of JM335 as demonstrated by a less intense 50 kb fragment compared with that seen at 2 x IC50. The main cell cycle effect of these drugs (at 2 x IC50) was a slowdown in S-phase traverse during which most but not all of the apoptosis appeared to occur. However, at 5 x IC50 of JM335 cells appeared frozen in all phases of the cell cycle with little progress from G1 to S accompanied by a build-up of cells in G2 indicative of a G2/M block. This difference in cell cycle effect may account for the reduced level of apoptosis at this concentration and a failure to engage apoptosis at higher concentrations. These data suggest that the nature of the platinum drug (and consequently, the nature of resultant DNA damage) may have important implications in determining the rate and mechanism of cell death in this cell line. The cell death effects observed with the trans complex JM335 may correlate with the induction of DNA single-strand breaks in this cell line. It has been previously demonstrated that cisplatin induces apoptosis in the CH1 human ovarian carcinoma cell line. This study demonstrates that two novel platinum (Pt) analogues JM149 and JM335, which are the cis and trans geometry respectively of ammine(cyclohexylamine)dihydroxodichloroPt(IV), initiate apoptosis in this cell line at physiologically relevant concentrations (IC50 values 2 h drug exposure were 35.3 microM for JM149 and 18.7 microM for JM335). While at equimolar drug concentrations there was a 2-fold higher level of total platinum-DNA adducts following exposure to JM335 vs JM149, at equitoxic concentrations, levels were similar (80 vs 70 pmol Pt mg-1 DNA respectively). Following a 2 h incubation with 2 x IC50 of both drugs, cells rounded up and detached in a time-dependent manner but with the kinetics of apoptosis being more rapid for JM335. The majority of detached cells exhibited morphology associated with apoptosis which was further supported by the presence of a 50 kb fragment detected in DNA lysates prepared from these cells. JM149 induced apoptosis across a range of concentrations (2 x, 5 x and 10 x IC50) with a 50 kb DNA fragment being detected at all concentrations. However, in marked contrast to this, JM335 failed to cause apoptosis at 10 x IC50, the detached cells neither displaying apoptotic morphology nor a detectable 50 kb DNA fragment. Moreover, these detached cells showed evidence of extensive vesiculation while the DNA remained normal in appearance and thus appeared to have died by a non-apoptotic mode. Apoptosis also appeared to be induced to a lesser extent at 5 x IC50 of JM335 as demonstrated by a less intense 50 kb fragment compared with that seen at 2 x IC50. The main cell cycle effect of these drugs (at 2 x IC50) was a slowdown in S-phase traverse during which most but not all of the apoptosis appeared to occur. However, at 5 x IC50 of JM335 cells appeared frozen in all phases of the cell cycle with little progress from G1 to S accompanied by a build-up of cells in G2 indicative of a G2/M block. This difference in cell cycle effect may account for the reduced level of apoptosis at this concentration and a failure to engage apoptosis at higher concentrations. These data suggest that the nature of the platinum drug (and consequently, the nature of resultant DNA damage) may have important implications in determining the rate and mechanism of cell death in this cell line. The cell death effects observed with the trans complex JM335 may correlate with the induction of DNA single-strand breaks in this cell line.It has been previously demonstrated that cisplatin induces apoptosis in the CH1 human ovarian carcinoma cell line. This study demonstrates that two novel platinum (Pt) analogues JM149 and JM335, which are the cis and trans geometry respectively of ammine(cyclohexylamine)dihydroxodichloroPt(IV), initiate apoptosis in this cell line at physiologically relevant concentrations (IC50 values 2 h drug exposure were 35.3 microM for JM149 and 18.7 microM for JM335). While at equimolar drug concentrations there was a 2-fold higher level of total platinum-DNA adducts following exposure to JM335 vs JM149, at equitoxic concentrations, levels were similar (80 vs 70 pmol Pt mg-1 DNA respectively). Following a 2 h incubation with 2 x IC50 of both drugs, cells rounded up and detached in a time-dependent manner but with the kinetics of apoptosis being more rapid for JM335. The majority of detached cells exhibited morphology associated with apoptosis which was further supported by the presence of a 50 kb fragment detected in DNA lysates prepared from these cells. JM149 induced apoptosis across a range of concentrations (2 x, 5 x and 10 x IC50) with a 50 kb DNA fragment being detected at all concentrations. However, in marked contrast to this, JM335 failed to cause apoptosis at 10 x IC50, the detached cells neither displaying apoptotic morphology nor a detectable 50 kb DNA fragment. Moreover, these detached cells showed evidence of extensive vesiculation while the DNA remained normal in appearance and thus appeared to have died by a non-apoptotic mode. Apoptosis also appeared to be induced to a lesser extent at 5 x IC50 of JM335 as demonstrated by a less intense 50 kb fragment compared with that seen at 2 x IC50. The main cell cycle effect of these drugs (at 2 x IC50) was a slowdown in S-phase traverse during which most but not all of the apoptosis appeared to occur. However, at 5 x IC50 of JM335 cells appeared frozen in all phases of the cell cycle with little progress from G1 to S accompanied by a build-up of cells in G2 indicative of a G2/M block. This difference in cell cycle effect may account for the reduced level of apoptosis at this concentration and a failure to engage apoptosis at higher concentrations. These data suggest that the nature of the platinum drug (and consequently, the nature of resultant DNA damage) may have important implications in determining the rate and mechanism of cell death in this cell line. The cell death effects observed with the trans complex JM335 may correlate with the induction of DNA single-strand breaks in this cell line. |
| Author | Robertson, D Cumber-Walsweer, Y Ormerod, M G Kelland, L R Titley, J C O'Neill, C F |
| Author_xml | – sequence: 1 givenname: C F surname: O'Neill fullname: O'Neill, C F organization: Cancer Research Campaign Centre for Cancer Therapeutics, Institute of Cancer Research, Sutton, Surrey, UK – sequence: 2 givenname: M G surname: Ormerod fullname: Ormerod, M G – sequence: 3 givenname: D surname: Robertson fullname: Robertson, D – sequence: 4 givenname: J C surname: Titley fullname: Titley, J C – sequence: 5 givenname: Y surname: Cumber-Walsweer fullname: Cumber-Walsweer, Y – sequence: 6 givenname: L R surname: Kelland fullname: Kelland, L R |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/8855971$$D View this record in MEDLINE/PubMed |
| BookMark | eNo9kD1PwzAQhj0UlbawsSJ5Qu2QYieOY49VxUelSizAGjn-IK4cO-QDNT-Df0wKFdPde3r06O7mYOKD1wDcYLTGKGH3xUGuMed0TRidgBlCKIsQj9ElmLftYYwcsWwKpoylKc_wDHxv6lB3obMSCq_gqIvE_0Rq56DSoiuh9aqXWsFigNK2v2zXCH_qhAsfvW5hMFCMgi_toKgq6_VSDtKFUh8HJ055pWw5qCYcg7KydKEJtROd9X213L2voAxV7fTxClwY4Vp9fa4L8Pb48Lp9jvYvT7vtZh9JQmgXkQRxgZhhkqICU5IaSpmOY4pirE1KpBRFijAvSEIzgijRhmtCDMNZnAhq4gW4-_PWTfgc9-_yyrani4XXoW_zjBHEEkxG8PYM9kWlVV43thLNkJ9_GP8A-LZ1kw |
| CitedBy_id | crossref_primary_10_1016_j_jinorgbio_2014_02_014 crossref_primary_10_1039_C4MT00112E crossref_primary_10_1016_S1040_8428_00_00053_6 crossref_primary_10_1007_s00280_010_1428_4 crossref_primary_10_1021_jm061219c crossref_primary_10_1038_sj_bjc_6694381 crossref_primary_10_1007_s10637_007_9062_7 crossref_primary_10_1021_jm1006534 crossref_primary_10_1016_S0162_0134_99_00143_9 crossref_primary_10_1007_s12094_007_0096_2 crossref_primary_10_1016_S0006_2952_00_00329_4 crossref_primary_10_1002_chem_201202050 crossref_primary_10_1016_S0887_2333_99_00082_X crossref_primary_10_1016_S0162_0134_99_00141_5 crossref_primary_10_1021_jm991015e crossref_primary_10_1002__SICI_1097_4547_20000501_60_3_388__AID_JNR14_3_0_CO_2_V crossref_primary_10_1016_S0009_2797_99_00115_5 crossref_primary_10_1016_j_bcp_2004_09_005 crossref_primary_10_1016_j_ejmech_2009_09_035 crossref_primary_10_1021_acs_inorgchem_5c01882 crossref_primary_10_1016_j_jinorgbio_2006_11_015 crossref_primary_10_1016_S1074_5521_99_80086_6 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1038/bjc.1996.486 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| ExternalDocumentID | 8855971 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- -Q- .55 .GJ 0R~ 23N 36B 39C 3V. 4.4 406 53G 5GY 5RE 6J9 70F 7RV 7X7 88E 8AO 8C1 8FI 8FJ 8R4 8R5 8WZ A6W AACDK AANZL AASML AATNV AAWTL AAYZH AAZLF ABAKF ABAWZ ABDBF ABLJU ABOCM ABUWG ABZZP ACAOD ACGFO ACGFS ACKTT ACPRK ACRQY ACUHS ACZOJ ADBBV ADFRT ADHDB AEFQL AEJRE AEMSY AENEX AEVLU AEXYK AFBBN AFKRA AFRAH AFSHS AGAYW AGHAI AGQEE AHMBA AHSBF AI. AIGIU AILAN AJRNO ALFFA ALMA_UNASSIGNED_HOLDINGS AMYLF AN0 AOIJS ASPBG AVWKF AXYYD AZFZN B0M BAWUL BBNVY BENPR BHPHI BKEYQ BKKNO BNQBC BPHCQ BVXVI CAG CCPQU CGR COF CS3 CUY CVF DIK DNIVK DPUIP DU5 E3Z EAD EAP EAS EBC EBD EBLON EBS ECM EE. EIF EIOEI EJD EMB EMK EMOBN EPL ESX EX3 F5P FDQFY FEDTE FERAY FIGPU FIZPM FRJ FSGXE FYUFA GX1 HCIFZ HMCUK HVGLF HYE HZ~ IH2 IWAJR J5H JSO JZLTJ KQ8 M1P M41 M7P NAO NAPCQ NPM NQJWS O9- OK1 P2P PQQKQ PROAC PSQYO Q2X RNT RNTTT ROL RPM SNX SNYQT SOHCF SOJ SRMVM SV3 SWTZT TAOOD TBHMF TDRGL TR2 TUS UDS UKHRP VH1 W2D WH7 WOW X7M Y6R ZGI ~02 ~8M 7X8 AAFWJ ATHPR |
| ID | FETCH-LOGICAL-c446t-4309a08f8c60b1645f668e226021ef54ccab5019b43674064ef9e44f81723a6f2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 28 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=10.1038/bjc.1996.486&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0007-0920 |
| IngestDate | Thu Oct 02 12:44:47 EDT 2025 Wed Feb 19 02:32:22 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c446t-4309a08f8c60b1645f668e226021ef54ccab5019b43674064ef9e44f81723a6f2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://www.nature.com/articles/bjc1996486.pdf |
| PMID | 8855971 |
| PQID | 78408314 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_78408314 pubmed_primary_8855971 |
| PublicationCentury | 1900 |
| PublicationDate | 1996-10-01 |
| PublicationDateYYYYMMDD | 1996-10-01 |
| PublicationDate_xml | – month: 10 year: 1996 text: 1996-10-01 day: 01 |
| PublicationDecade | 1990 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | British journal of cancer |
| PublicationTitleAlternate | Br J Cancer |
| PublicationYear | 1996 |
| SSID | ssj0009087 |
| Score | 1.65376 |
| Snippet | It has been previously demonstrated that cisplatin induces apoptosis in the CH1 human ovarian carcinoma cell line. This study demonstrates that two novel... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 1037 |
| SubjectTerms | Antineoplastic Agents - pharmacology Apoptosis Cell Cycle - drug effects Cell Death DNA, Neoplasm - drug effects DNA, Neoplasm - metabolism Drug Screening Assays, Antitumor Female Flow Cytometry Humans Isomerism Organoplatinum Compounds - pharmacology Ovarian Neoplasms - drug therapy Ovarian Neoplasms - pathology Platinum - metabolism Time Factors Tumor Cells, Cultured |
| Title | Apoptotic and non-apoptotic cell death induced by cis and trans analogues of a novel ammine(cyclohexylamine)dihydroxodichloroplatinum(IV) complex |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/8855971 https://www.proquest.com/docview/78408314 |
| Volume | 74 |
| WOSCitedRecordID | wos10.1038/bjc.1996.486&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07T8MwELYKRYiFd0V5emBoh9CkdhJHQkIVogKJVh0Adascx1aL2jr0peZn8I855wETYmCJYiexk_PF_r7z-YzQNXGI44Yc2AljQFCY8i0OqN_i3CeMC5f4Kl0o_Ox3u6zfD3oldFushTFulUWfmHbUkRbGRt7wgYkw4tC7-MMye0aZudV8A40NVIYqA6PTfv8nVnhgsyxipjHGBU07d3u3CWuE78Is0_NuKPN-h5bpENPe-9_L7aPdHFriVqYLB6gkp4dou5NPnh-hz1as44WGq5hPIwy83-LfOcaAjyODBzGwdGjvCIcJFqN5eu_CjGhwlll65lgrzKGAlRxjPplA6TWRiLEeynUCGgbpejQaJtFMrzXUPhzrmY6N0910Oak9vdVx6sgu18fotf3wcv9o5TsyWAJo48KixA64zRQTnh0C0XKV5zEJCA6QglQuBXUIXQCNISWeD1CBShVIShUDmES4p5oVtAlfJ08QNoHjiHJDQiNKm1yFklPBCCRtaUBIFV0Voh6Axhsp8KnUy_mgEHYVVbLWGsRZYI4BY4YfOad_PnqGdlLv69Qp7xyVFfzq8gJtidViNJ9dpnoEx26v8wVc8NTe |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Apoptotic+and+non-apoptotic+cell+death+induced+by+cis+and+trans+analogues+of+a+novel+ammine%28cyclohexylamine%29dihydroxodichloroplatinum%28IV%29+complex&rft.jtitle=British+journal+of+cancer&rft.au=O%27Neill%2C+C+F&rft.au=Ormerod%2C+M+G&rft.au=Robertson%2C+D&rft.au=Titley%2C+J+C&rft.date=1996-10-01&rft.issn=0007-0920&rft.volume=74&rft.issue=7&rft.spage=1037&rft_id=info:doi/10.1038%2Fbjc.1996.486&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-0920&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-0920&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-0920&client=summon |